New horizons in the management of patients with cystinuria

Current Opinion in Urology

Volumn 20, Issue 2, 2010, Pages 169-173

  Tiselius, Hans Göran ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acetazolamide; Cystine; Cystinuria; Diagnosis; Recurrence prevention; Stone clinics; Urolithiasis

Indexed keywords

ACETAZOLAMIDE; ACETYLCYSTEINE; ALKALI; BUCILLAMINE; CALCIUM PHOSPHATE; CYSTINE; NITROPRUSSIDE SODIUM; PENICILLAMINE; TIOPRONIN; TROMETAMOL;

ALKALINIZATION; CHELATION; CHEMICAL ANALYSIS; CHROMOSOME 19; CHROMOSOME 2; COMPUTER ASSISTED TOMOGRAPHY; CRYSTAL; CYSTINURIA; DIAGNOSTIC ACCURACY; DILUTION; DISEASE ASSOCIATION; FOLLOW UP; GENETICS; HEREDITY; HETEROZYGOTE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; KIDNEY FUNCTION; KIDNEY SURGERY; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; REVIEW; STONE DISSOLUTION; STONE FORMATION; URINE PH; UROLITHIASIS;

CYSTINURIA; HUMANS;

EID: 76749143659     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328333b674     Document Type: Review

References (41)

1. Rogers A, Kalakish S, Desai RA, Assimos DG. Management of cystinuria. Urol Clin N Am 2007; 34:347-362.
2. Sakhaee K, Sutton RAL. Pathogenesis and management of cystinuria. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, editors. Kidney stones: medical and surgical management. Philadelphia, Pennsylvania: Lippincott- Raven Publishers; 1996. pp. 1007-1017.
3. Biyani CS, Cartledge JJ. Cystinuria: diagnosis and management. EAU-EBU Update Series 2006; 4:175-183.
4. Aydogdu SD, Kirel B, Coskun T, Kose S. Prevalence of cystinuria among elementary school children in Eskisehir, Turkey. Scand J Urol Nephrol 2009; 43:138-141.
5. Inci BA, Arican F, Emeksiz S, Dallar Y. Risk factors for nephrolithiasis in children. World J Urol 2008; 26:627-630.
6. Chiu PK, Chan ES, Hou SS, Ng CF. Cystinuria: a rare diagnosis that should not be missed. Hong Kong Med J 2008; 14:399-401.
7. Sevedzadeh A, Momtaz HE, Moradi MR, Moradi A. Pediatric cystine calculi in west Iran: a study of 22 cases. Urol J 2006; 3:134-138.
8. Motley G, Dalrympie N, Keeslin C, et al. Hounsfield unit density in the determination of urinary stone composition. Urology 2001; 58:170-173.
9. Kim SC, Burns EK, Lingeman JE, et al. Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy. Urol Res 2007; 35:319-324.
10. Kim SC, Hatt EK, Lingeman JE, et al. Cystine: helical computerized tomography characterization of rough and smooth calculi in vitro. J Urol 2005; 174:1468-1470.
11. Boll DT, Patil NA, Paulson EK, et al. Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition - pilot study. Radiology 2009; 250: 813-820.
12. Crofton PM, Squires N, Davidson DF, et al. Reliability of urine collection pads for routine metabolic biochemistry in infants and young children. Eur J Pediatr 2008; 167:1313-1319.
13. Ahlstrand C, Tiselius HG. Treatment of cystine urolithiasis by a combination of extracorporeal shock wave lithotripsy and chemolysis. J Stone Dis 1993; 5:32-38.
14. Harada T, Ko Z, Kamidono S. Experience with extracorporeal shock wave lithotripsy for cystine calculi in 20 renal units. J Endourol 1992; 6:213-215.
15. Kachel T, Vijan S, Dretler S. Endourological experience with cystine calculi and a treatment algorithm. J Urol 1991; 145:25-28.
16. Martin X, Salas M, Labeeuw M, et al. Treatment of cystine calculi using intraurologic methods and extracorporeal lithotripsy [French]. Ann Urol (Paris) 1991; 25:19-24.
17. Tiselius H-G. Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, editors. Kidney stones: medical and surgical management. Philadelphia, Pennsylvania: Lippincott-Raven Publishers; 1996. pp. 33-64.
18. Marshall RW, Robertson WG. Nomograms for the estimation of saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate and cystine. Clin Chim Acta 1976; 72:253-260.
19. Evan AP. Physiology and etiology of stone formation in the kidney and urinary tract. Pediatric Nephrol 2009. [Epub ahead of print]
20. Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin N Am 2007; 34:295-313.
21. Evan AP, Coe FL, Lingeman JE. Renal crystal deposition and histopathology in patients with cystine stones. Kidney Int 2006; 69:2227-2235.
22. Dohlin DJ, Asplin JR, Flagen L, et al. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol 2005; 19:429-432.
23. Goodyer P. The molecular basis of cystinuria. Nephron Exp Nephrol 2004; 98:45-49.
24. Sayer JA. The genetics of nephrolithiasis. Nephron Exp Nephrol 2008; 110:e37-e43.
25. Mattoo A, Goldfarb DS. Cystinuria. Semin Nephrol 2008; 28:181-191.
26. Harnevik L, Fjellstedt E, Molbaek A, et al. Mutation analysis of SLC7A9 in cystinuric patients in Sweden. Genet Test 2003; 7:13-20.
27. Fjellstedt E, Harnevik L, Jeppsson J-O, et al. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds. Urol Res 2003; 31:417-425.
28. Di Perna M, Louizou E, Fischetti L, et al. Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes. Genet Test 2008; 12:351-355.
29. Martens K, Jaeken J, Matthiis G, Creemers JW. Multisystem disorder syndromes associated with cystinuria type 1. Curr Mol Med 2008; 8:544-550.
30. Knoll T, Sagi S, Trojan L, et al. In vitro and ex vivo gene delivery into proximal tubular cells by means of laser energy: a potential approach of curing cystinuria? Urol Res 2004; 32:129-132.
31. Ahmed K, Khan MS, Thomas K, et al. Management of cystinuric patients: an observational, retrospective, single-centre analysis. Urol Int 2008; 80:141-144.
32. Bouzidi H, Daudon M. Cystinuria from diagnosis and follow-up. Ann Biol Clin (Paris) 2007; 65:473-481.
33. Sterret SP, Penniston KL, Wolf JS Jr, Nakada SY. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. Urology 2008; 72:278-281.
34. Lindell A ° , Denneberg T, Edholm E, Jeppson JO. The effect of sodium intake on cystinuria with and without tiopronin treatment. Nephron 1995; 71:407-415.
35. DeBerardinis RJ, Coughlin CR 2nd, Kaplan P. Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children. J Urol 2009; 180:2620-2623.
36. Wendt-Nordahl G, Meister L, Michel S, Knoll T. Evaluation of alkalinization and chelating agent therapy for cystinuria in animal model [abstract #340]. Eur Urol 2009; S8:205.
37. Fjellstedt E, Denneberg T, Jeppson JO. Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria. Urol Res 2001; 29:303-310.
38. Koide T, Yamaguchi S, Utsonomiya M, Yoshioka T. A new therapeutic agent for cystinuria. In: Urolithiasis 2. Proceedings of the VIIth International Symposium on Urolithiasis; 24-27 August 1992; Cairns, Australia. New York, USA: Plenum Press; 1994. pp. 571-574.
39. Haritopoulos K, Fojtik P, Cross W, Cartledge J. Experience of a dedicated metabolic clinic in the management of cystine stone disease [abstract #339]. Eur Urol 2009; S8:205.
40. Tostivint I, Conort P, Pieroni L, et al. Recurrent urinary stones: impact of a new approach using participative pedagogy based on objectives to prevent recurrences [abstract #388]. Eur Urol 2009; S8:205.
41. Wendt-Nordahl G, Sagi S, Bolenz C, et al. Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology. Urol Res 2008; 36:25-29.